It has been demonstrated that the increase in M2 macrophages during thyroid cancer progression contributes to cancer aggressiveness by promoting angiogenesis and immune escape, particularly in BRAF-mutated cancer [8,10]. The gene discussed is BRAF; the disease is thyroid cancer.